GlassScriptPhysician profile
Don L Henslee
NPI 1285657551
$14,740.73
in general payments reported to CMS, 2019-2025
49 companies · $6,397 in 2025
The $6,397 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,128 · 2020: $462 · 2021: $809 · 2022: $3,046 · 2023: $942 · 2024: $957 · 2025: $6,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,639 · Food and Beverage: $2,187 · Travel and Lodging: $376 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,638.89 |
| Food and Beverage | $2,186.64 |
| Travel and Lodging | $375.74 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $5,667.14 | 2024-2025 | Nanoknife, Nanoknife |
| Teleflex LLC | $2,967.80 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $1,567.65 | 2019 | |
| Sumitomo Pharma America, INC. | $565.35 | 2023-2025 | Orgovyx, Gemtesa |
| Isoray, INC | $375.76 | 2020-2024 | Brachytherapy Source |
| Janssen Biotech, INC. | $352.81 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $344.71 | 2019-2024 | Veozah |
| Pfizer INC. | $339.93 | 2019-2025 | |
| Abbvie INC. | $262.72 | 2019-2025 | |
| Boston Scientific Corporation | $222.58 | 2019-2025 | Spaceoar Vue System - 10ml |
| Urogen Pharma, INC. | $192.39 | 2022-2025 | Jelmyto |
| Telix Pharmaceuticals | $173.39 | 2024 | Illuccix |
| Dendreon Pharmaceuticals LLC | $155.09 | 2019-2025 | Provenge |
| Palette Life Sciences, INC. | $143.32 | 2022-2023 | |
| Amgen INC. | $127.98 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Henslee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.